Terray Therapeutics
Terray Therapeutics Raises $120M in Series B
Quick Facts
Terray Therapeutics Raises $120M in Series B
Terray Therapeutics has successfully raised $120M in a Series B at a $600M valuation led by Bedford Ridge Capital, NVentures.
Company Overview
Terray Therapeutics is a Biotech company headquartered in Los Angeles, CA, founded in 2018 with 150+ employees.
AI platform for small molecule drug discovery and development
Fundraising Details
- Amount Raised: $120M
- Round Type: Series B
- Valuation: $600M
- Date: 2024-10-20
- Investors: Bedford Ridge Capital, NVentures
About Terray Therapeutics
AI platform for small molecule drug discovery and development The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Los Angeles, CA
- Founded: 2018
- Team Size: 150+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Terray Therapeutics's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Terray Therapeutics's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $600M valuation marks an important milestone for Terray Therapeutics, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Terray Therapeutics is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-10-20. For more information about Terray Therapeutics, visit their headquarters at Los Angeles, CA.
About the Author
Related Company Reports
Anthropic Raises $2B in Series D
Anthropic, a AI/ML company based in San Francisco, CA, has raised $2B in Series D at a $18B valuation led by Menlo Ventures, Spark Capital, Google.
xAI Raises $6B in Series C
xAI, a AI/ML company based in San Francisco, CA, has raised $6B in Series C at a $40B valuation led by Sequoia Capital, a16z, Valor Equity.
Adept AI Raises $350M in Series B
Adept AI, a AI/ML company based in San Francisco, CA, has raised $350M in Series B at a $1B valuation led by General Catalyst, Spark Capital, Addition.